(19)
(11)
EP 1 365 761 A1
(12)
(43)
Date of publication:
03.12.2003
Bulletin 2003/49
(21)
Application number:
00989288.6
(22)
Date of filing:
18.12.2000
(51)
International Patent Classification (IPC)
7
:
A61K
31/44
,
A61K
31/55
,
A61P
9/00
,
A61P
9/02
,
A61P
9/04
,
A61P
9/10
,
A61P
9/12
,
A61P
11/00
,
A61P
27/00
,
A61P
43/00
// A61K31:44, A61K31:55
(86)
International application number:
PCT/US0034/246
(87)
International publication number:
WO 0204/9645
(
27.06.2002
Gazette 2002/26)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(71)
Applicant:
Novartis AG
4056 Basel (CH)
(72)
Inventors:
DALEY, William, Lionel
Morris Plains, NJ 07950 (US)
WEBB, Randy, Lee
Flemington, NJ 08822 (US)
(74)
Representative:
Grubb, Philip William
Novartis AG,Corporate Intellectual Property
4002 Basel
4002 Basel (CH)
(54)
THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL